|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $26,720,000 | $21,436,000 | $21,948,000 | $15,481,000 | $15,491,000 | $21,437,444 | $18,101,570 |
| Streptomycins & their derivs.; salts thereof | $1,898,000 | $2,038,000 | $1,775,000 | $890,000 | $1,239,000 | $1,242,866 | $2,607,413 |
| Tetracyclines & their derivs.; salts thereof | $31,116,000 | $33,366,000 | $19,676,000 | $22,335,000 | $27,698,000 | $29,860,575 | $24,794,497 |
| Chloramphenicol & its derivs.; salts thereof | $1,715,000 | $2,396,000 | $2,508,000 | $2,159,000 | $1,099,000 | $1,256,116 | $4,495,641 |
| Erythromycin & its derivs.; salts thereof | $4,715,000 | $6,213,000 | $12,666,000 | $6,599,000 | $5,839,000 | $2,542,707 | $6,680,968 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $154,286,000 | $147,017,000 | $130,408,000 | $116,785,000 | $107,232,000 | $89,537,998 | $113,301,437 |
| Total | $220,450,000 | $212,466,000 | $188,981,000 | $164,249,000 | $158,598,000 | $145,877,706 | $169,981,526 |
|
|
